Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NEK1 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | BEND6 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | SIRPB2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | ALG5 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | MEFV | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | EHD2 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | SCN8A | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | MXI1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | SLC12A9 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | SENP1 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |